KEGG   DRUG: Abaloparatide acetate
Entry
D11563                      Drug                                   

Name
Abaloparatide acetate (JAN)
Formula
C174H300N56O49. (C2H4O2)x
Remark
Therapeutic category: 2439
ATC code: H05AA04
Chemical structure group: DG03050
Product (DG03050): D10885<US>
Efficacy
Osteoporosis agent, Osteogenesis stimulant, Parathyroid hormone receptor 1 agonist
Target
PTH1R [HSA:5745] [KO:K04585]
  Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04961  Endocrine and other factor-regulated calcium reabsorption
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
  H05 CALCIUM HOMEOSTASIS
   H05A PARATHYROID HORMONES AND ANALOGUES
    H05AA Parathyroid hormones and analogues
     H05AA04 Abaloparatide
      D11563  Abaloparatide acetate (JAN)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  24  Hormones
   243  Thyroid and parathyroid hormone preparations
    2439  Others
     D11563  Abaloparatide acetate (JAN)
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Secretin receptor family
   Parathyroid hormone
    PTH1R
     D11563  Abaloparatide acetate (JAN)
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11563
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11563
Other DBs
PubChem: 384585539
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system